Report cover image

Global Induced Pluripotent Stem Cell (iPSC) Market 2025 – 2034

Published Nov 01, 2025
SKU # CSTM20669762

Description

Induced Pluripotent Stem Cell (iPSC) Market Size, Trends and Insights By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), By Application (Drug Development, Tissue Engineering & Regenerative Medicine, Disease Modelling, Toxicology Research), By End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034

Table of Contents

Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology
Chapter 2. Executive Summary
2.1 Global Induced Pluripotent Stem Cell (iPSC) Market, (2025 – 2034) (USD Billion)
2.2 Global Induced Pluripotent Stem Cell (iPSC) Market : snapshot
Chapter 3. Global Induced Pluripotent Stem Cell (iPSC) Market – Industry Analysis
3.1 Induced Pluripotent Stem Cell (iPSC) Market: Market Dynamics
3.2 Market Drivers
3.2.1 Technological Advancements in iPSC Reprogramming
3.2.2 Expansion of Clinical Applications
3.2.3 Increasing Investment in Stem Cell Research
3.2.4 Regulatory Support and Standardization
3.2.5 Advancements in Disease Modelling and Drug Discovery.
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porters Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Derived Cell Type
3.7.2 Market attractiveness analysis By Application
3.7.3 Market attractiveness analysis By End-Use
Chapter 4. Global Induced Pluripotent Stem Cell (iPSC) Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Induced Pluripotent Stem Cell (iPSC) Market: company market share, 2024
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
Chapter 5. Global Induced Pluripotent Stem Cell (iPSC) Market – Derived Cell Type Analysis
5.1 Global Induced Pluripotent Stem Cell (iPSC) Market overview: By Derived Cell Type
5.1.1 Global Induced Pluripotent Stem Cell (iPSC) Market share, By Derived Cell Type, 2024 and 2034
5.2 Hepatocytes
5.2.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Hepatocytes, 2025 – 2034 (USD Billion)
5.3 Fibroblasts
5.3.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Fibroblasts, 2025 – 2034 (USD Billion)
5.4 Keratinocytes
5.4.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Keratinocytes, 2025 – 2034 (USD Billion)
5.5 Amniotic Cells
5.5.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Amniotic Cells, 2025 – 2034 (USD Billion)
5.6 Others
5.6.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Others, 2025 – 2034 (USD Billion)
Chapter 6. Global Induced Pluripotent Stem Cell (iPSC) Market – Application Analysis
6.1 Global Induced Pluripotent Stem Cell (iPSC) Market overview: By Application
6.1.1 Global Induced Pluripotent Stem Cell (iPSC) Market share, By Application, 2024 and 2034
6.2 Drug Development
6.2.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Drug Development, 2025 – 2034 (USD Billion)
6.3 Tissue Engineering & Regenerative Medicine
6.3.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Tissue Engineering & Regenerative Medicine, 2025 – 2034 (USD Billion)
6.4 Disease Modelling
6.4.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Disease Modelling, 2025 – 2034 (USD Billion)
6.5 Toxicology Research
6.5.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Toxicology Research , 2025 – 2034 (USD Billion)
Chapter 7. Global Induced Pluripotent Stem Cell (iPSC) Market – End-Use Analysis
7.1 Global Induced Pluripotent Stem Cell (iPSC) Market overview: By End-Use
7.1.1 Global Induced Pluripotent Stem Cell (iPSC) Market share, By End-Use, 2024 and 2034
7.2 Academic & Research Institutes
7.2.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Academic & Research Institutes, 2025 – 2034 (USD Billion)
7.3 Pharmaceutical & Biotechnology Companies
7.3.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Pharmaceutical & Biotechnology Companies, 2025 – 2034 (USD Billion)
7.4 Others
7.4.1 Global Induced Pluripotent Stem Cell (iPSC) Market by Others, 2025 – 2034 (USD Billion)
Chapter 8. Induced Pluripotent Stem Cells (iPSC) Market – Regional Analysis
8.1 Global Induced Pluripotent Stem Cells (iPSC) Market Regional Overview
8.2 Global Induced Pluripotent Stem Cells (iPSC) Market Share, by Region, 2024 & 2034 (USD Billion)
8.3. North America
8.3.1 North America Induced Pluripotent Stem Cells (iPSC) Market, 2025 – 2034 (USD Billion)
8.3.1.1 North America Induced Pluripotent Stem Cells (iPSC) Market, by Country, 2025 – 2034 (USD Billion)
8.4 North America Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034
8.4.1 North America Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034 (USD Billion)
8.5 North America Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034
8.5.1 North America Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034 (USD Billion)
8.6 North America Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034
8.6.1 North America Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034 (USD Billion)
8.7. Europe
8.7.1 Europe Induced Pluripotent Stem Cells (iPSC) Market, 2025 – 2034 (USD Billion)
8.7.1.1 Europe Induced Pluripotent Stem Cells (iPSC) Market, by Country, 2025 – 2034 (USD Billion)
8.8 Europe Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034
8.8.1 Europe Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034 (USD Billion)
8.9 Europe Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034
8.9.1 Europe Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034 (USD Billion)
8.10 Europe Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034
8.10.1 Europe Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034 (USD Billion)
8.11. Asia Pacific
8.11.1 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, 2025 – 2034 (USD Billion)
8.11.1.1 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, by Country, 2025 – 2034 (USD Billion)
8.12 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034
8.12.1 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034 (USD Billion)
8.13 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034
8.13.1 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034 (USD Billion)
8.14 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034
8.14.1 Asia Pacific Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034 (USD Billion)
8.15. Latin America
8.15.1 Latin America Induced Pluripotent Stem Cells (iPSC) Market, 2025 – 2034 (USD Billion)
8.15.1.1 Latin America Induced Pluripotent Stem Cells (iPSC) Market, by Country, 2025 – 2034 (USD Billion)
8.16 Latin America Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034
8.16.1 Latin America Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034 (USD Billion)
8.17 Latin America Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034
8.17.1 Latin America Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034 (USD Billion)
8.18 Latin America Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034
8.18.1 Latin America Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034 (USD Billion)
8.19. The Middle-East and Africa
8.19.1 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, 2025 – 2034 (USD Billion)
8.19.1.1 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, by Country, 2025 – 2034 (USD Billion)
8.20 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034
8.20.1 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, by Derived Cells Type, 2025 – 2034 (USD Billion)
8.21 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034
8.21.1 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, by Application, 2025 – 2034 (USD Billion)
8.22 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034
8.22.1 The Middle-East and Africa Induced Pluripotent Stem Cells (iPSC) Market, by End-Use, 2025 – 2034 (USD Billion)
Chapter 9. Company Profiles
9.1 Aesculap
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Bioventus
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 DePuy Synthes
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 Disc Dynamics
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Exactech
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 Globus Medical
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments
9.7 Insightec
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Business Strategy
9.7.5 Recent Developments
9.8 Integra LifeSciences
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Business Strategy
9.8.5 Recent Developments
9.9 K2M Group Holdings
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Business Strategy
9.9.5 Recent Developments
9.10 Medtronic
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Business Strategy
9.10.5 Recent Developments
9.11 NuVasive
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Business Strategy
9.11.5 Recent Developments
9.12 Orthofix Medical
9.12.1 Overview
9.12.2 Financials
9.12.3 Product Portfolio
9.12.4 Business Strategy
9.12.5 Recent Developments
9.13 Spinal Elements
9.13.1 Overview
9.13.2 Financials
9.13.3 Product Portfolio
9.13.4 Business Strategy
9.13.5 Recent Developments
9.14 Stryker
9.14.1 Overview
9.14.2 Financials
9.14.3 Product Portfolio
9.14.4 Business Strategy
9.14.5 Recent Developments
9.15 Zimmer Biomet
9.15.1 Overview
9.15.2 Financials
9.15.3 Product Portfolio
9.15.4 Business Strategy
9.15.5 Recent Developments
9.16 Others.
9.16.1 Overview
9.16.2 Financials
9.16.3 Product Portfolio
9.16.4 Business Strategy
9.16.5 Recent Developments
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.